Ah previous studies of the localization of utrophin (the dystrophin-re
lated protein) in muscle and other tissues have been performed only wi
th antibodies against the C-terminal region of the protein. Since seve
ral short forms of dystrophin, the apodystrophins, are produced from t
he 3' end of the dystrophin gene, there is a possibility that similar
short forms of utrophin exist and that these could be responsible for
some of the many different localizations of 'utrophin' in muscle. We h
ave produced a new panel of 15 mAbs against the N-terminal region of u
trophin and me have used it together with mAbs against the C-terminal
region to show that full-length utrophin is present at neuromuscular j
unctions, in nerves, blood vessels and capillaries in normal muscle an
d in the sarcolemma of patients with muscular dystrophy and dermatomyo
sitis. However, two of the 15 mAbs also recognised rat/mouse utrophin
and both of these detected an additional 62 kDa protein on Western blo
ts of rat C6 glioma cells. This potential 62 kDa 'apo-utrophin' was no
t detected in human cerebral cortex, in rat Schwannoma cells nor in an
y of the non-nerve cells and tissues tested.